鑻辨枃鍚嶇ū Anti-Bik

涓枃鍚嶇ū 淇冨噵浜ik铔嬬櫧鎶楅珨

婵� 搴� 1mg/1ml

瑕� 鏍� 0.1ml/100渭g 0.2ml/200渭g

鎶楅珨渚嗘簮 Rabbit

鍏嬮殕椤炲瀷 polyclonal

浜ゅ弶鍙嶆噳 Human, Mouse, Rat

鐢㈠搧椤炲瀷 涓€鎶�

鐮旂┒闋樺煙 绱拌優鐢熺墿 鍏嶇柅瀛� 绱拌優鍑嬩骸

铔嬬櫧鍒嗗瓙閲� predicted molecular weight: 18kDa

鎬� 鐙€ Lyophilized or Liquid

鍏� 鐤� 鍘� KLH conjugated synthetic peptide derived from humanBik

浜� 鍨� IgG

绱斿寲鏂规硶 affinity purified by Protein A

鍎� 瀛� 娑� 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

鐢㈠搧鎳夌敤 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

锛堢煶锠熷垏鐗囬渶鍋氭姉鍘熶慨寰╋級

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

淇濆瓨姊濅欢 Store at -20 掳C for oneyear.

鍒� 鍚� Apoptosis inducer NBK; BBC1; Bcl-2-interactingkiller; BCL2 interacting killer; bhikhari; BIK; Bik-like killer protein;BIK_HUMAN; BIP 1; BIP1; BP 4; BP4; cb 60; NBK.